Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 401287
                    [Title] => Study reinforces cilostazol's safety in managing PAD, stroke
                    [Summary] => Cilostazol, the first line drug for treatment of Peripheral Arterial Disease (PAD), has stood the test of time and the ...
                    [DatePublished] => 2008-09-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. SAMUEL MONEY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 401287
                    [Title] => Study reinforces cilostazol's safety in managing PAD, stroke
                    [Summary] => Cilostazol, the first line drug for treatment of Peripheral Arterial Disease (PAD), has stood the test of time and the ...
                    [DatePublished] => 2008-09-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Study reinforces cilostazol's safety in managing PAD, stroke

September 18, 2008 - 12:00am

Cilostazol, the first line drug for treatment of Peripheral Arterial Disease (PAD), has stood the test of time and the ...

Science and Environment